CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background and purpose: We investigated associations between severity of cognitive impairment, cerebrospinal fluid (CSF) concentrations of total‐tau (t‐tau) protein and tau phosphorylated at threonin 181 (p‐tau 181) and regional glucose metabolism measured with 18F‐fluorodeoxyglucose‐positron emission tomography (18F‐FDG‐PET) in patients with probable Alzheimer’s disease (AD). Methods: In 38 patients (mean age 66.5 ± 8.0 years) with AD, Mini‐Mental State Examination (MMSE) scores were evaluated and CSF levels of t‐tau and p‐tau 181 measured. All patients underwent an 18F‐FDG‐PET scan. Image analysis including correlation analysis and principal component analysis (PCA) were performed using SPM5 and VINCI. Results: Dementia severity (MMSE 21.2 ± 4.9) correlated well with metabolic impairment especially in left hemisphere association areas that are typically affected in patients with AD (e.g. inferior parietal lobule, r = 0.512; medial temporal gyrus, r = 0.478; inferior temporal gyrus, r = 0.488; precuneus, r = 0.468; PCA: r = 0.639, F = 7.751; all P < 0.001). There were no associations between t‐tau and p‐tau 181 with dementia severity and only weak correlations between t‐tau and cerebral glucose metabolism (superior parietal gyrus, r = −0.325, P < 0.05; precentral gyrus r = −0.418, P < 0.01; amygdala r = −0.362, P < 0.05). No correlations were found between p‐tau 181 and regional hypometabolism in FDG‐PET. Conclusion: MMSE and CSF t‐tau represent different aspects of disease severity. Whilst MMSE is closely related to impaired cerebral glucose metabolism, CSF t‐tau is less closely related and appears to be less well suited for assessment of disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700 · cited 1×
“In a study of MCI patients there were no correlations between time to conversion to AD and concentration of CSF t-tau and p-tau181 [47].”
BackgroundCSF markers for incipient Alzheimer's disease
Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291 · cited 1×
“Phospho-tau (p-tau) is considered to represent an abnormal hyperphosphorylation state of the tau protein in the brain and is involved in the subsequent formation of NFTs in AD which may be related to elevated cerebrospinal fluid (CSF) p-tau levels compared with healthy controls [5].”
BackgroundSelf-citationDiscrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET
Herholz, K., Salmon, E., Perani, D., Baron, J.-C., Holthoff, V., Frölich, L., Schönknecht, P., Ito, K., Mielke, R., & Kalbe, E. (2002) · NeuroImage · doi:10.1006/nimg.2002.1208 · Cited by 832 · cited 4×
“Hypometabolism related to the degree of impairment in AD patients has been detected in the posterior cingulate cortex, the temporoparietal association cortex and the prefrontal association cortex [11].”
BackgroundResultSelf-citationTau is essential to β-amyloid-induced neurotoxicity
Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092136199 · Cited by 807
Buerger, K., Ewers, M., Pirttila, T., Zinkowski, R., Alafuzoff, I., Teipel, S. J., DeBernardis, J., Kerkman, D., McCulloch, C., Soininen, H., et al. (2006) · Brain · doi:10.1093/brain/awl269 · Cited by 586
Self-citationHampel, H., Buerger, K., Zinkowski, R., Teipel, S. J., Goernitz, A., Andreasen, N., Sjoegren, M., DeBernardis, J., Kerkman, D., Ishiguro, K., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.95 · Cited by 434 · cited 2×
“Cerebrospinal fluid sampling and processing were performed as described previously [6,16].”
BackgroundMethodSelf-citationHampel, H., Teipel, S. J., Fuchsberger, T., Andreasen, N., Wiltfang, J., Otto, M., Shen, Y., Dodel, R., Du, Y., Farlow, M., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001473 · Cited by 287
Self-citationMinoshima, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1995) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199507000-00006 · Cited by 252 · cited 1×
“Intensity normalization was performed by dividing the mean value of each VOI by the mean value of a VOI both of the right and the left pons, which was used as the reference region for glucose metabolism [33].”
Method
Cited by
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI
Landau, S. M., Harvey, D., Madison, C. M., Koeppe, R. A., Reiman, E. M., Foster, N. L., Weiner, M. W., & Jagust, W. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.07.002 · Cited by 750
Relationships between biomarkers in aging and dementia
Jagust, W. J., Landau, S. M., Shaw, L. M., Trojanowski, J. Q., Koeppe, R. A., Reiman, E. M., Foster, N. L., Petersen, R. C., Weiner, M. W., Price, J. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc010c · Cited by 456
“27 These studies are difficult to compare because they used different subject groups, different imaging methods, different immunoassays, and different tau phosphorylation sites.”
Total and phosphorylated tau protein as biological markers of Alzheimer’s disease
Hampel, H., Blennow, K., Shaw, L. M., Hoessler, Y. C., Zetterberg, H., & Trojanowski, J. Q. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.010 · Cited by 389
“Multicenter (Haense et al., 2008) CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease AD (n=38) Sandwich ELISA (Innotest; Innogenetics, Gent, Belgium)”
BackgroundSelf-citation
Metadata
- Authors
- Haense, C., Buerger, K., Kalbe, E., Drzezga, A., Teipel, S. J., Markiewicz, P., Herholz, K., Heiss, W. D., & Hampel, H.
- Venue
- European Journal of Neurology
- Publisher
- Wiley
- Published
- 2008-10-06
- Volume
- 15
- Issue
- 11
- Pages
- 1155-1162
- ISSN
- 1351-5101 (ISSN-L)
- 1468-1331
- OpenAlex
- W2013267861
- Cited by
- 55
- References
- 9
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer’s disease. https://app.cochat.ai/papers/10.1111/j.1468-1331.2008.02274.x
- The paper
- Haense, C., Buerger, K., Kalbe, E., Drzezga, A., Teipel, S. J., Markiewicz, P., Herholz, K., Heiss, W. D., & Hampel, H. (2008). CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer’s disease. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2008.02274.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.